Ernexa Therapeutics Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2012
Total Assets: $12.7M
Liabilities Breakdown FY2012
Total Liabilities: $4.8M
Asset Breakdown
Total Assets: $12.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.7M | 21.5% |
| Accounts Receivable | $610.0K | 4.8% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.8M | 29.9% |
| Goodwill | $1.3M | 10.0% |
| Intangible Assets | $579.0K | 4.6% |
| Other Assets | $3.7M | 29.2% |
Liabilities Breakdown
Total Liabilities: $4.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $549.0K | 11.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $4.2M | 88.5% |